Gliomas and nephrotic syndrome: Coincidental comorbidity or pathogenic association?
-
-
REFERENCES
[1] Singh, N., Baby, D., Rajguru, J.P., et al. (2019). Inflammation and cancer. Ann. Afr. Med. 18: 121−126. DOI: 10.4103/aam.aam_56_18. [2] Bae, J.M., Chung, K.Y., Yun, S.J., et al. (2019). Markedly reduced risk of internal malignancies in patients with vitiligo: A nationwide population-based cohort study. J. Clin. Oncol. 37: 903−911. DOI: 10.1200/JCO.18.01223. [3] Hemminki, K., Li, X., Sundquist, K., et al. (2008). Cancer risk in hospitalized rheumatoid arthritis patients. Rheumatology (Oxford) 47: 698−701. DOI: 10.1093/rheumatology/ken130. -
ABOUT THIS ARTICLE
Cite this article:
Yang M., Lv Y., Deng Y., et al., (2024). Gliomas and nephrotic syndrome: Coincidental comorbidity or pathogenic association? The Innovation Medicine 2(2): 100067. https://doi.org/10.59717/j.xinn-med.2024.100067
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Yang M., Lv Y., Deng Y., et al., (2024). Gliomas and nephrotic syndrome: Coincidental comorbidity or pathogenic association? The Innovation Medicine 2(2): 100067. https://doi.org/10.59717/j.xinn-med.2024.100067
Format
Content
DownLoad:
-
Figure 1.
The radiological and pathological findings of the tumor
